Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy

Current Heart Failure Reports

Volumn 8, Issue 3, 2011, Pages 212-218

  Swetz, Keith M ^a   Ottenberg, Abigale L ^a   Freeman, Monica R ^a   Mueller, Paul S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Advance care planning; Destination therapy; DT; End of life; End stage heart failure; ESHF; Heart failure; LVAD; Medical ethics; Palliative care; Patient caregiver communication; Preparedness planning; Psychosocial issues; Quality of care; Quality of life; Ventricular assist device

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; HEART FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL ETHICS; PALLIATIVE THERAPY; PATIENT CARE; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SOCIOECONOMICS; TERMINAL CARE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADVANCE DIRECTIVES; CAREGIVERS; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PALLIATIVE CARE; QUALITY OF LIFE; TERMINAL CARE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80055054281     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0060-x     Document Type: Article

References (50)

1. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post- REMATCH era: implications for patient selection. Circulation. 2007;116:497-505. (Pubitemid 47450258)
2. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
3. Long JW, Healy AH, Rasmusson BY, et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg. 2008;135:1353-1360.
4. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9-17. (Pubitemid 40038090)
5. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
6. Boilson B, Schirger J, Durham III J, et al. Transformation of LVAD destination therapy, "good to great": ever increasing survival benefit. (Abstract 3662). Circulation. 2009;120:S844.
7. Rogers JG, Aaronson KD, Boyle AJ, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55:1826-1834.
8. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS Annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011;30:115-123.
9. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535-541.
10. Krumholz HM, Phillips RS, Hamel MB, et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Circulation. 1998;98:648-655. (Pubitemid 28387491)
11. Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024. (Pubitemid 32824149)
12. Aranda JM, Rogers JG, Aronson KD, et al. Quality of life improvements are greater in destination therapy than bridge to transplant patients with a continuous flow left ventricular assist device. J Am Coll Cardiol. 2010;55:A22.E209.
13. Starling RC. Improved quantity and quality of life: a winning combination to treat advanced heart failure. J Am Coll Cardiol. 2010;55:1835-1836.
14. Spertus J, Peterson E, Conard MW, et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150:707-715. (Pubitemid 41396503)
15. Hu FB, Stampfer MJ, Solomon C, et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med. 2001;134:96-105. (Pubitemid 32096336)
16. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
17. Freeman M. Psychosocial assessment and discharge planning: importance of the social worker in the LVAD multidisciplinary team. In: Joyce D, Joyce L, Locke M, editors. Mechanical circulatory support: principles and applications. 1st ed: McGraw- Hill Professional; 2011 (in press).
18. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant. Heart Fail Rev 2009;14:21-28.
19. Grady KL, Meyer PM, Dressler D, et al. Change in quality of life from after left ventricular assist device implantation to after heart transplantation. J Heart Lung Transplant. 2003;22:1254-1267. (Pubitemid 37324700)
20. Shapiro PA, Levin HR, Oz MC. Left ventricular assist devices: psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry. 1996;18:30S-35S. (Pubitemid 26396802)
21. Petrucci R, Kushon D, Inkles R, et al. Cardiac ventricular support considerations for psychiatry. Psychosomatics. 1999;40:298-303. (Pubitemid 29315949)
22. Grady KL, Meyer PM, Dressler D, et al. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg. 2004;77:1321-1327. (Pubitemid 38452372)
23. Casida JM, Peters RM, Magnan MA. Self-care demands of persons living with an implantable left-ventricular assist device. Res Theory Nurs Pract. 2009;23:279-293.
24. Swetz K, Freeman M, AbouEzzeddine O, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 2011;86:in press.
25. Grady KL, Meyer P, Mattea A, et al. Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant. 2001;20:657-669. (Pubitemid 32515207)
26. Bunzel B, Laederach-Hofmann K, Wieselthaler G, et al. Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant. 2007;26:384-389. (Pubitemid 46498779)
27. Bunzel B, Laederach-Hofmann K, Wieselthaler GM, et al. Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners. Transplant Proc. 2005;37:1365-1368. (Pubitemid 40590889)
28. Wilson SR, Givertz MM, Stewart GC, Mudge GH, Jr. Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 2009;54:1647-1659.
29. Zambroski CH, Combs P, Cronin SN, Pfeffer C. Edgar Allan Poe, "the pit and the pendulum," and ventricular assist devices. Crit Care Nurse 2009;29:29-39.
30. Marcuccilli L, Casida JJ, Peters RM, Wright S. Sex and intimacy among patients with implantable left-ventricular assist devices. J Cardiovasc Nurs 2011.
31. MacIver J, Ross HJ, Delgado DH, et al. Community support of patients with a left ventricular assist device: the Toronto General Hospital experience. Can J Cardiol 2009;25:e377-e381.
32. Seemuth SC, Richenbacher WE. Education of the ventricular assist device patient's community services. ASAIO J. 2001;47:596-601. (Pubitemid 33064148)
33. Dudzinski DM. Ethics guidelines for destination therapy. Ann Thorac Surg. 2006;81:1185-1188.
34. Mueller P, Swetz K, Freeman M, et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010;85:791-797.
35. Sulmasy DP. Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med. 2008;23 Suppl 1:69-72. (Pubitemid 350295395)
36. Pellegrino ED. Decisions to withdraw life-sustaining treatment: a moral algorithm. JAMA. 2000;283:1065-1067. (Pubitemid 30112225)
37. Rhymes JA, McCullough LB, Luchi RJ, et al. Withdrawing very low-burden interventions in chronically ill patients. JAMA. 2000;283:1061-1063. (Pubitemid 30112224)
38. Snyder L, Leffler C. Ethics manual: fifth edition. Ann Intern Med. 2005;142:560-582.
39. Mueller PS, Hook CC, Hayes DL. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc. 2003;78:959-963. (Pubitemid 36936127)
40. Gostin LO. Deciding life and death in the courtroom. From Quinlan to Cruzan, Glucksberg, and Vacco-a brief history and analysis of constitutional protection of the 'right to die'. JAMA. 1997;278:1523-1528. (Pubitemid 27488282)
41. Singer PA, Robertson G, Roy DJ. Bioethics for clinicians: 6. Advance care planning. CMAJ. 1996;155:1689-1692. (Pubitemid 27022834)
42. Rizzieri AG, Verheijde JL, Rady MY, McGregor JL. Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med 2008;3:20.
43. Swetz K, Mueller P, Ottenberg A, et al. The use of advance directives among patients with left ventricular assist devices. Hosp Pract (Minneap) 2011;39:78-84.
44. Swetz K, Freeman M, Mueller P, Park S. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:1081. Epub 2010 May 26.
45. Bramstedt KA, Wenger NS. When withdrawal of life-sustaining care does more than allow death to take its course: the dilemma of left ventricular assist devices. J Heart Lung Transplant. 2001;20:544-548. (Pubitemid 32410015)
46. Wiegand DLM, Kalowes PG. Withdrawal of cardiac medications and devices. AACN Adv Crit Care. 2007;18:415-425.
47. Landzaat LH, Sinclair CT, Rosielle DA. Continuous-flow left ventricular assist device. N Engl J Med. 2010;362:1149. author reply 1149.
48. MacIver J, Ross HJ. Withdrawal of ventricular assist device support. J Palliat Care. 2005;21:151-156. (Pubitemid 41444986)
49. Von Gunten C, Weissman D. Symptom control for ventilator withdrawal in the dying patient, 2nd edition. Fast Facts and Concepts. July 2005; 34. Available at: http://www.eperc.mcw.edu/fastfact/ff-034.htm.
50. Campbell ML. How to withdraw mechanical ventilation: a systematic review of the literature. AACN Adv Crit Care. 2007;18:397-403. quiz 344-395.